Dr. Soliman Abdel Kader Fakeeh Hospital Company (SASE: 4017)
Health Care · Health Care Providers & Services · SA
SR34.28
-0.35% today · -19.2% 1Y
Dr. Soliman Abdel Kader Fakeeh Hospital Company (SASE: 4017) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $2.10B.
Over the last twelve months the share price has lost 19.2%, trading between 27.20 and 42.84.
Tweenvest scores Dr. Soliman Abdel Kader Fakeeh Hospital Company across four factors: quality 74/100, value 59/100, growth 39/100, dividend 22/100. Its strongest factor is quality.
4017 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.10B
- Revenue (TTM)
- $825.24M
- P/E
- 33.95
- EPS
- 1.01
- Dividend yield
- 0.96%
- Beta (5Y)
- -0.09
- 52-week high
- SR42.84
- 52-week low
- SR27.20
- Avg volume (3M)
- —
- Shares outstanding
- 230.00M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| EBOS Group LimitedNZSE: EBO | $2.20B | NZ$18.98 | +0.74% |
| Progyny, Inc.NasdaqGS: PGNY | $2.14B | $27.85 | -0.29% |
| Pediatrix Medical Group, Inc.NYSE: MD | $2.11B | $26.99 | +1.30% |
| NeoGenomics, Inc.NasdaqCM: NEO | $2.10B | $16.14 | -1.28% |
| Addus HomeCare CorporationNasdaqGS: ADUS | $2.09B | $117.19 | +2.50% |
| China Meheco Group Co., Ltd.SHSE: 600056 | $2.04B | CN¥9.14 | +2.93% |
| Qingdao Baheal Medical INC.SZSE: 301015 | $2.04B | CN¥25.94 | +1.01% |
| GeneDx Holdings Corp.NasdaqGS: WGS | $2.01B | $65.75 | -2.35% |
Figures last refreshed Oct 11, 2026.